All lobbying filings

AMERICAN KIDNEY FUND

Lobbying for AMERICAN KIDNEY FUND

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $230,000.00 expenses · posted Apr 20, 2026

Official filing document

Bills named in this filing 10

HR 4582
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surge…
HR 4583
Living Donor Protection Act of 2025
S 1552
Living Donor Protection Act of 2025
HR 1518
New Era of Preventing End-Stage Kidney Disease Act
HR 2199
Restore Protections for Dialysis Patients Act
S 1173
Restore Protections for Dialysis Patients Act
HR 5259
Permanent OPTN Fee Authority Act
S 2751
Permanent OPTN Fee Authority Act
S 2730
Kidney Care Access Protection Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 1

Health Issues

Access to Genetic Counselor Services Act Living Donor Protection Act: H.R. 4582; H.R 4583; S. 1552 Appropriations-NIH, NIDDK, Kidney Research The New Era for Preventing End-Stage Kidney Disease Act of 2025: H.R. 1518. Restore Protections for Dialysis Patients Act: H.R. 2199; S. 1173. Enhanced Advance Premium Tax Credits (eAPTCs) Permanent OPTN Fee Authority Act: H.R.5259; S. 2751. Kidney Care Access Protection Act: S.2730. H.R. 1 CMS-1830-P: End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model Proposed Local Coverage Determination (LCD) MolDX: Molecular Testing for Solid Organ Allograft Rejection Proposed LCD ID: DL40060 Proposed Local Coverage Determination (LCD) MolDX: Molecular Testing for Solid Organ Allograft Rejection Proposed LCD ID: DL40058

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.